Toggle Nav

MLN 2480

In stock
Catalog No.
A3627
Pan-Raf kinase inhibitor,investigational
Grouped product items
SizePriceStock Qty
10mg
$200.00
Please inquiry
5mg
$120.00
Ship with 10-14 days
50mg
$680.00
Please inquiry

Tel: +1-832-696-8203

Email: [email protected]

Worldwide Distributors

Background

MLN2480 is an potent pan-RAF kinase inhibitor.

In vitro: MLN2480 inhibits MAPK pathway signaling in BRAF mutant and some RAS mutant preclinical cancer models at concentrations that are tolerated in vivo. In vitro analysis of this drug combination of MLN2480 and TAK-733 in cell proliferation assays demonstrates synergistic activity [1].

In vivo: MLN2480 is most potent in BRAF mutant melanoma models but also has single agent activity in some RAS mutant models. The MLN2480 and TAK-733 combination inhibits the growth of a broader range of RAS mutant tumor models than MLN2480 single agent, including primary human tumor xenograft models of melanoma and CRC [2].

Clinical trial: In the first-in-human study (n=24), the safety profile of MLN2480 up to 200 mg Q2D was acceptable. Accrual continues at 200 mg to confirm the MTD [2].

References:
[1] Elizabeth Grace Carideo Cunniff, Julie Zhang, Jouhara Chouitar, et al.  Combination treatment with the investigational RAF kinase inhibitor MLN2480 and the investigational MEK kinase inhibitor TAK-733 inhibits the growth of BRAF mutant and RAS mutant preclinical models of melanoma and CRC. Mol Cancer Ther November 2013 12; C146
[2] Drew Warren Rasco, Anthony J.   Olszanski, Amita Patnaik, et al. MLN2480, an investigational oral pan-RAF kinase inhibitor, in patients (pts) with relapsed or refractory solid tumors: Phase I study. J Clin Oncol 31, 2013 (suppl; abstr 2547)

Chemical Properties

Physical AppearanceA solid
StorageStore at -20°C
M.Wt506.29
Cas No.1096708-71-2
FormulaC17H12Cl2F3N7O2S
SynonymsBIIB024, BIIB 024, BIIB-024, MLN2480, MLN 2480, MLN-2480
Solubility≥104 mg/mL in DMSO with gentle warming, <2.625 mg/mL in H2O, ≥50.6 mg/mL in EtOH with gentle warming
Chemical Name2-[(1R)-1-[(6-amino-5-chloropyrimidine-4-carbonyl)amino]ethyl]-N-[5-chloro-4-(trifluoromethyl)pyridin-2-yl]-1,3-thiazole-5-carboxamide
SDFDownload SDF
Canonical SMILESCC(C1=NC=C(S1)C(=O)NC2=NC=C(C(=C2)C(F)(F)F)Cl)NC(=O)C3=C(C(=NC=N3)N)Cl
Shipping ConditionEvaluation sample solution : ship with blue ice.All other available size: ship with RT , or blue ice upon request
General tipsFor obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months.

Biological Activity

Description MLN 2480 is an oral, selective inhibitor of Raf kinases.
Targets Raf kinases          
IC50            

Quality Control